Previous reports demonstrated increased expression of IGFBP2 in various types of cancer tissue, including glioma [11], colorectal cancer [12], lung cancer [13], and gastric cancer [14, 15], and high expression of IGFBP2 was associated with worse survival. Here, IGFBP2 is linked to glioma.